Ftse Mib
33.762,25
-0,83%
DAX
18.720,01
-1,47%
S&P 500
5.702,55
-0,19%
NASDAQ
17.948,32
-0,36%
Bitcoin
63.261,81
0,09%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Axogen Inc (AXGN) Axogen Inc (AXGN) Notizie

Axogen Inc

AXGN
14,09
-0,58 (-3,95%)
21 Set 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
17/9/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/9/202422:00EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
06/9/202413:09EDGAR2Form 8-K - Current report
06/9/202413:00GLOBEAxogen Completes Submission of Biologics License Application..
05/9/202422:33EDGAR2Form 144 - Report of proposed sale of securities
05/9/202403:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202403:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202402:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202402:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202401:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/9/202423:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/9/202413:00GLOBEAxogen Reports Inducement Grant to New Employee Under NASDAQ..
21/8/202422:31EDGAR2Form 144 - Report of proposed sale of securities
13/8/202423:00EDGAR2Form 144 - Report of proposed sale of securities
13/8/202422:18GLOBECytoSorbents Appoints Peter J. Mariani Chief Financial..
12/8/202416:59EDGAR2Form 144 - Report of proposed sale of securities
09/8/202422:36EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/8/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202422:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/8/202422:05EDGAR2Form 8-K - Current report
08/8/202422:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202413:14EDGAR2Form 8-K - Current report
08/8/202413:05GLOBEAxogen, Inc. Announces New Leadership Appointments
08/8/202413:00GLOBEAxogen, Inc. Reports Second Quarter 2024 Financial Results
23/7/202413:00GLOBEAxogen, Inc. to Report Second Quarter 2024 Financial Results..
01/7/202413:00GLOBECompany Reports Inducement Grants to Non-Executive New..
24/6/202413:00GLOBEAxogen, Inc Announces Full Launch of Avive+ Soft Tissue..
11/6/202400:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202400:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202400:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202400:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202400:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202400:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202400:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:31EDGAR2Form 8-K - Current report
06/6/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:30GLOBEAxogen Processing Center (APC) Celebrates its Opening with..
16/5/202413:00GLOBEAxogen Inc. Initiates Rolling Submission of Biologics..
14/5/202413:00GLOBEAxogen, Inc to Participate at Leerink Partners Healthcare..
02/5/202413:00GLOBEAxogen, Inc Reports First Quarter 2024 Financial Results
29/4/202422:50GLOBEAxogen Announces First Surgical Implants of Avive+ Soft..
16/4/202413:00GLOBEAxogen, Inc. to Report First Quarter 2024 Financial Results..
08/3/202423:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202423:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:38EDGAR2Form 8-K - Current report
08/3/202400:12EDGAR2Form 144 - Report of proposed sale of securities
07/3/202422:18EDGAR2Form 144 - Report of proposed sale of securities
06/3/202414:59EDGAR2Form S-8 - Securities to be offered to employees in employee..
Apertura: 14,64 Min: 13,94 Max: 14,66
Chiusura: 14,67

La tua Cronologia

NASDAQ
AXGN
Axogen
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network